Role of Insulin Resistance in MAFLD
Open accessThe DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Abstract
Many studies have reported that metabolic dysfunction is closely involved in the complex mechanism underlying the development of non-alcoholic fatty liver disease (NAFLD), which has prompted a movement to consider renaming NAFLD as metabolic dysfunction-associated fatty liver disease (MAFLD). Metabolic dysfunction in this context encompasses obesity, type 2 diabetes mellitus, hypertension, dyslipidemia, and metabolic syndrome, with insulin resistance as the common underlying pathophysiology. Imbalance between energy intake and expenditure results in insulin resistance in various tissues and alteration of the gut microbiota, resulting in fat accumulation in the liver. The role of genetics has also been revealed in hepatic fat accumulation and fibrosis. In the process of fat accumulation in the liver, intracellular damage as well as hepatic insulin resistance further potentiates inflammation, fibrosis, and carcinogenesis. Increased lipogenic substrate supply from other tissues, hepatic zonation of Irs1, and other factors, including ER stress, play crucial roles in increased hepatic de novo lipogenesis in MAFLD with hepatic insulin resistance. Herein, we provide an overview of the factors contributing to and the role of systemic and local insulin resistance in the development and progression of MAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Given that insulin resistance (IR) is widely recognized as the key underlying mechanism of metabolic syndrome, it is reasonable to consider IR as a central factor in the pathogenesis of MASLD, which can be viewed as the hepatic manifestation of metabolic syndrome [2,9-12].”
The cited source says what the claim attributes to it.
In the citing paper
“ChREBP, which is activated by carbohydrate uptake [9,34,78,83].”
The cited source says what the claim attributes to it.
In the citing paper
“Among the core insulin signaling mediators—including INSR, IRS1, IRS2, AKT1, and AKT2—IRS1 shows marked zonal expression, with approximately 2-fold higher levels in PV compared to PP regions [9,20].”
In the citing paper
“Many studies have shown that insulin- resistant conditions are accompanied by a substantial increase in MTP and apolipoprotein C3 (ApoCIII) expression and the production of hepatic VLDL-ApoB and VLDL-TG [2, 9,108,111].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
MORA, A., LIPINA, C., TRONCHE, F., SUTHERLAND, C., & ALESSI, D. R. (2005) · Biochemical Journal · doi:10.1042/bj20041782 · Cited by 92
RetractedSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · cited 2×
“, hepatocyte ballooning), with or without fibrosis [2].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Younossi, Z., Anstee, Q. M., Marietti, M., Hardy, T., Henry, L., Eslam, M., George, J., & Bugianesi, E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.109 · Cited by 5,249 · cited 1×
“The global prevalence of NAFLD is estimated at 24%; the highest rates are reported from South America and the Middle East, followed by Asia, the USA, and Europe [3].”
BackgroundSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Eslam, M., Newsome, P. N., Sarin, S. K., Anstee, Q. M., Targher, G., Romero-Gomez, M., Zelber-Sagi, S., Wai-Sun Wong, V., Dufour, J.-F., Schattenberg, J. M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.039 · Cited by 4,472
Cited by
Items 201–300 of 506
Jeon, S., Lee, H., Kim, S. Y., Lee, C.-H., & Lim, Y. (2024) · Nutrients · doi:10.3390/nu17010007 · Cited by 8
Zhang, X., Wang, R., Tang, M., Jin, C., Zhang, G., & Zou, W. (2026) · Environmental Science & Technology · doi:10.1021/acs.est.5c18229 · Cited by 8
Xin, Z., Feng, L., Yu, Q., Shi, Y., Tang, T., Tong, X., Hu, S., You, Y., Zhang, S., Zhang, X., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03888-x · Cited by 8
Xiao, P., Ye, Z., Li, X., Feng, Q., & Su, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1540255 · Cited by 7
Xu, F., Dou, L., Yu, D., Wu, X., Liu, L., Man, Y., & Huang, X. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.97217 · Cited by 7
Wang, Y.-J., Jin, C., Ke, J.-F., Wang, J., Ma, Y.-L., Lu, J., Li, M., & Li, L. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s389794 · Cited by 7
Xu, Y., Chen, T., Ding, H., Chen, Q., & Fan, Q. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02312-2 · Cited by 7
Correlation of non-alcoholic fatty liver disease and neurodegenerative disorders
Jadhav, P. A., Thomas, A. B., Chopada, V. M., Bokaria, P. V., Deokate, S. B., Chougule, P. S., Chavan, P. N., & Chitlange, S. S. (2024) · Egyptian Liver Journal · doi:10.1186/s43066-024-00386-9 · Cited by 7
Zambrano-Vásquez, O. R., Cortés-Camacho, F., Castañeda‐Sánchez, J. I., Aréchaga-Ocampo, E., Valle-Velázquez, E., Cabrera-Angeles, J. C., Sánchez-Gloria, J. L., Sánchez‐Muñoz, F., Arellano-Buendía, A. S., Sánchez‐Lozada, L. G., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123638 · Cited by 7
The Role of Solute Carrier Family Transporters in Hepatic Steatosis and Hepatic Fibrosis
Zhang, C., Yang, X., Yi, X., Li, H., Zeng, C., & Chen, M. (2025) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2024.00348 · Cited by 7
Liu, L., Sun, W., Tang, X., Zhen, D., Guan, C., Fu, S., & Liu, J. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112337 · Cited by 7
Ferraz‐Amaro, I., Hernández-Camba, A., Palau, M. C., Alvarez-Buylla, N. H., de Vera-González, A., Delgado, A. G., Heras-Recuero, E., & González-Gay, M. Á. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216430 · Cited by 7
Lukić, I., Ranković, N., Savić, N., Ranković, D., Popov, Ž., Vujić, A., & Folic, N. D. (2022) · Healthcare · doi:10.3390/healthcare10050921 · Cited by 7
Zhang, Y., Bu, Y., Zhao, R., & Han, C. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241274350 · Cited by 7
Li, J., Ma, X., Yi, Y., Li, L.-R., Zhi-yong, X., & Chang, Y. (2024) · Current Medical Science · doi:10.1007/s11596-024-2868-0 · Cited by 7
Xiong, K.-G., Lin, T.-S., Lin, Q.-B., Kong, J., & Ke, K.-Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-03244-9 · Cited by 7
Hairi, H. A., Ibrahim, N. ‘., Sadikan, M. Z., Jayusman, P. A., & Shuid, A. N. (2024) · Bioimpacts · doi:10.34172/bi.30378 · Cited by 7
Sun, Q., Guo, C., Liu, Y., Zhang, Q., Liu, L., Sun, S., Wang, X., Zhou, M., Jia, Q., Song, K., et al. (2023) · Food & Function · doi:10.1039/d3fo01396k · Cited by 7
Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options
Ren, R., Liang, X., & Wei, X. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00486-5 · Cited by 6
Microbiome and Genetic Factors in the Pathogenesis of Liver Diseases
Miteva, D., Peshevska-Sekulovska, M., Snegarova, V., Peruhova, M., Vasilev, G., Vasilev, G., Sekulovski, M., Lazova, S., Gulinac, M., Tomov, L., et al. (2023) · Gastroenterology Insights · doi:10.3390/gastroent14040041 · Cited by 6
Inter-organ Crosstalk and the Effect on the Aging Process in Obesity
Armutçu, F., & Özen, O. A. (2023) · Current Aging Science · doi:10.2174/1874609816666230223110458 · Cited by 6
Basumatary, D., Das, S., Devi, M. B., Devi, G. S., Sarma, P., Mukherjee, A. K., Khan, M. R., & Borah, J. C. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115285 · Cited by 6
Wang, W., Chen, Y., Tu, M., & Chen, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1384059 · Cited by 6
Ren, X., Yan, C., Liu, X. Y., Jia, X., Chen, Y., Zhao, H., Feng, Y., Xue, G., Cui, J., Ke, Y., et al. (2025) · Journal of Gastroenterology · doi:10.1007/s00535-025-02332-x · Cited by 6
Muscle Strength and Cardiovascular Health in MASLD: A Prospective Study
Kumbaroğlu, F. B., Balaban, Y. H., & Düger, T. (2025) · Medicina · doi:10.3390/medicina61020247 · Cited by 6
Cao, R., Jiang, H., Zhang, Y., Guo, Y., & Zhang, W. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1368483 · Cited by 6
Concurrence of hyperinsulinemia and hyperuricemia significantly augmented all-cause mortality
Acevedo-Fernández, M., Porchia, L. M., Elguezabal-Rodelo, R. G., López‐Bayghen, E., & González-Mejía, M. E. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.05.023 · Cited by 6
Gao, S., Peng, X., Zhang, S., Yang, J., Guo, S., Li, Y., Ma, R., Hu, Y., Mulatibieke, K., Zhang, X., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-12658-4 · Cited by 6
Han, X., Kong, J., Zhang, H., Zhao, Y., Zheng, Y., & Wei, C. (2024) · Obesity Facts · doi:10.1159/000536447 · Cited by 6
Nardolillo, M., Rescigno, F., Bartiromo, M., Piatto, D., Guarino, S., Marzuillo, P., del Giudice, E. M., & Sessa, A. D. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i15.2081 · Cited by 6
Li, Y., Dai, C., Ruan, Y., Yang, H., Zeng, H., Huang, R., Wang, J., Dai, M., Hao, J., Wang, L., et al. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae007 · Cited by 6
Elbouny, H., Amssayef, A., Benjamaa, R., Ajebli, M., Ouahzizi, B., Bammou, M., Sellam, K., & Alem, C. (2025) · Nutrire · doi:10.1186/s41110-024-00307-1 · Cited by 6
Tseng, P.-L., Chung, T., & Lee, C.-H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032453 · Cited by 6
Yu, Y., Zhu, G., Zhang, Z., Wang, H., Zeng, L., Xia, J., Liu, X., Fang, C., Liu, S., Yang, Y., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-07857-y · Cited by 6
Venu, S., & Raj, M. (2026) · BMJ Paediatrics Open · doi:10.1136/bmjpo-2025-003846 · Cited by 5
Guo, N., Shi, H., Zhang, H., & Wang, H. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03561-w · Cited by 5
Moon, S. Y., Son, M., Kang, Y. W., Koh, M., Lee, J. Y., & Baek, Y. H. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03877-0 · Cited by 5
FERNANDES, M. K. C., Paula, M. D., Oliveira, R., Santos, J. P. D., Mancini, M. C., & Hottz, E. D. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s556871 · Cited by 5
The Role of Pesticides in the Pathogenesis of Diabetes: A Review of Possible Mechanisms
Flores-Gutierrez, C. A., Torres-Sánchez, E. D., Reyes-Uribe, E., Torres-Jasso, J. H., & Flores, J. S. (2025) · Biocell · doi:10.32604/biocell.2025.062225 · Cited by 5
Hentu, D. S. R. M., Muchlisin, M. A., Jamil, A. S., Astuti, E. J., & Rafikayanti, A. (2024) · Pharma xplore Jurnal Sains dan Ilmu Farmasi · doi:10.36805/jpx.v9i1.6964 · Cited by 5
Zhu, N., Song, Y., Zhang, C., Wang, K., & Han, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1294425 · Cited by 5
Guo, C., Zhang, Y., Xue, H., Zhao, X., Wang, B., Deng, L., Zhu, X., Zhang, X., Zhang, Y., & Liu, Y. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s530855 · Cited by 5
Mojtahedi, K., Joukar, F., Fahim, S., Yeganeh, S., Asgharnezhad, M., Shafaghi, A., Asl, S. F., & Mansour‐Ghanaei, F. (2023) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2023.177224.1590 · Cited by 5
Metabolic Dysfunction Associated to Steatotic Liver Disease: A Review
Torres, J. V. D., Guerrero, V. R. V., Gómez, J. P. V., Miranda, F. J. P., Álvarez, L. R. O., Insignares, J. D. L., Mares, M., Ortiz, H. M. R., & Mendoza‐Torres, E. (2025) · Metabolic Syndrome and Related Disorders · doi:10.1177/15578518251382048 · Cited by 4
A microphysiological model of human MASLD reveals paradoxical response to resmetirom
Hellen, D. J., Ungerleider, J. L., Tevonian, E. N., Sphabmixay, P., Roy, P., Meimetis, N., Presutti, F., Williams, A. M., Ogi, R., Lewis, C. A., et al. (2026) · Communications Biology · doi:10.1038/s42003-025-09484-9 · Cited by 4
Li, X., Xia, X., Jiang, B., Yao, Y., Ding, F., & Qin, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1330283 · Cited by 4
Wang, T., Gong, B., Shi, K., Hu, G., Sun, L., & Xu, Y. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120702 · Cited by 4
何曉碩, 郭战利, & Chen, Q. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10067-0 · Cited by 4
Lin, Y., Lun, W., Bai, Y., Che, Q., Cao, H., Guo, J., & Su, Z. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106946 · Cited by 4
Huang, C., Chen, M., Sun, Y., Zhang, L., & Liu, W. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1689280 · Cited by 4
Xu, L., Han, J., Yang, Z., Yang, Y., Chen, J., Wu, X., Wang, Q., & Hong, Y. (2023) · PubMed Central · doi:10.12122/j.issn.1673-4254.2023.07.13 · Cited by 4
Matcha Green Tea Improves Cafeteria-Diet-Induced NAFLD by Modulating the Gut Microbiota in Rats
Chong, H.-C., Tang, S. X., Tseng, Y.-C., Yang, S., Watanabe, Y., Yamada, S., Yang, Y. S. H., & Chen, Y. (2025) · Nutrients · doi:10.3390/nu17193051 · Cited by 4
Sotoudeheian, M., Azarbad, R., Mirahmadi, S., & Farahmandian, N. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328328193241029103831 · Cited by 4
Liu, X., Peng, Z., Ma, S., Liu, F., Liu, M., Li, X., & Zheng, R. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05943-8 · Cited by 4
Sotoudeheian, M. (2024) · The International Journal of Gastroenterology and Hepatology Diseases · doi:10.2174/0126662906302851240604042954 · Cited by 4
Hoteit, M., Dagher, M., Tzenios, N., Kaaki, N. A., Rkein, G., Chahine, A., Sacre, Y., Hotayt, S., Matar, R., Hallal, M., et al. (2024) · Healthcare · doi:10.3390/healthcare12050591 · Cited by 4
Analysis of subgingival microbial community structure in MAFLD patients with periodontitis
He, H., Zhu, J., Li, C., Shen, Q., Cao, J., Ma, J., Feng, Z., Li, Z., & Song, T. (2025) · Clinical Oral Investigations · doi:10.1007/s00784-025-06564-2 · Cited by 4
Evaluation of [18F]F-TZ3108 for PET Imaging of Metabolic-Associated Fatty Liver Disease
Huang, P., Li, Z., Peng, T., Yang, J., Bi, L., Huang, G., Qiu, Y., Yang, M., Ye, P., Huang, M., et al. (2022) · Molecular Imaging and Biology · doi:10.1007/s11307-022-01740-2 · Cited by 4
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis
Basile, U., Carnazzo, V., Basile, V., Pignalosa, S., D’Ambrosio, F., Vinante, I., Tagliaferro, M., Niccolini, B., Santo, R. D., Rapaccini, G. L., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26135942 · Cited by 4
Dicheva, D. T., Brekhunets, R. M., Андреев, Д. Н., Lebedeva, E. G., Евгеньевна, Б. О., Golovkina, N. L., Shaburov, R. I., Cheremushkin, S. V., & Maev, I. V. (2025) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-401 · Cited by 4
Remnant cholesterol, a potential risk factor of metabolic dysfunction-associated fatty liver disease
Hao, X., Li, D., Huang, X., Wang, T., Wu, P., Shen, L., Zhang, K., & Sun, S. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00898-0 · Cited by 4
FGF1 orchestrates circadian hepatic triglyceride secretion
Sermikli, B. P., Liu, S., Kim, K., Hases, L., van Zutphen, T., Untereiner, A. A., Torres, J., He, M., Crossley, L., Dai, Y. D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70849-7 · Cited by 4
The Mitochondrial–Autophagy Axis in MASLD : Mechanisms, Crosstalk, and Therapeutic Targets
Bhaduri, G., Kalia, A., Saboo, B., & Bandyopadhyay, S. (2026) · Comprehensive physiology · doi:10.1002/cph4.70155 · Cited by 4
Wei, S., Yu, S., Qian, C., Lan, Y., & Huang, X. (2026) · European journal of medical research · doi:10.1186/s40001-026-03906-y · Cited by 4
Liang, H., & Song, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332177 · Cited by 4
Deficiency of Ugcg in LSECs alleviates high-fat diet-induced MASLD
Han, R., Li, Y., Liu, Y., Li, M., Ren, L., Lin, W., & Jiang, Y. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000793 · Cited by 3
Srikanth, P., Shaik, K. M., Patibandla, V., Kumar, D., & Nandi, S. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101425 · Cited by 3
Recent advances in the treatment of non-alcoholic fatty liver disease with astragaloside IV
Wang, H., Jiang, Y., Wang, S., Lu, C., Tang, L., Gu, T., & Shu, S. (2025) · Acta Pharmaceutica · doi:10.2478/acph-2025-0022 · Cited by 3
Association Between Bioimpedance-Determined Metabolic Age and MASLD Risk Scores in Spanish Workers
Gallegos, I. R., Busquets-Cortés, C., Paublini, H., López‐González, Á. A., Rifá, E. M.-A., López, P. J. T., & Ramírez‐Manent, J. I. (2025) · Metabolites · doi:10.3390/metabo15050343 · Cited by 3
Zhou, Y., Li, J., Li, L., Shen, N., Li, X.-Y., Bao, N.-M., Yang, X., Qiu, B., Chen, Z., Gu, W., et al. (2025) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2025.102236 · Cited by 3
Silymarin for treatment of adults with nonalcoholic fatty liver disease
Wang, C., Kanaan, G., Shang, Y., Chai, L., Li, H., & Qi, X. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015524 · Cited by 3
Xu, M., Han, S., Wu, Q., Ma, S., Cai, H., Xue, M., Liu, F., Xiao, X., Chen, X., & Lin, M. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0947 · Cited by 3
Exploring mechanisms of insulin action and strategies to treat diabetes
Sasako, T. (2024) · Endocrine Journal · doi:10.1507/endocrj.ej24-0003 · Cited by 3
Aker, A., Tarchitzky, T., Avidan, Y., & Zafrir, B. (2025) · CJC Open · doi:10.1016/j.cjco.2025.01.005 · Cited by 3
Enfermedad por esteatohepatitis no alcohólica en pacientes diabéticos tipo 2: artículo de revisión
Miranda, G. (2023) · Horizonte Médico (Lima) · doi:10.24265/horizmed.2023.v23n2.13 · Cited by 3
Zheng, X., & Wang, H. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04190-6 · Cited by 3
Zhou, W., Ren, S., Lu, Y., Wang, Y., Feng, L., & Gao, Q. (2024) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2024.05.527 · Cited by 3
Risk of Insulin Resistance: Comparison of the Commerce vs. Industry Sector and Associated Variables
Vicioso, M. P. F.-F., Sbert, P. R., López‐González, Á. A., Ramírez‐Manent, J. I., Fernández, J. L. D. B., & Herrero, M. T. V. (2025) · Diseases · doi:10.3390/diseases13050150 · Cited by 3
Zhang, J., Wang, H., Wang, Q., Mo, J., Fu, L., & Peng, S. (2024) · Mammalian Genome · doi:10.1007/s00335-024-10078-9 · Cited by 3
Xu, W., Du, Z., Wang, J., Gong, Y., Yu, J., Wang, X., Sun, X., & Gong, Y. (2025) · Peptides · doi:10.1016/j.peptides.2025.171427 · Cited by 3
ER Stress Response Failure and Steatohepatitis Comorbid with Diabetes
Sasako, T., & Ueki, K. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100054 · Cited by 3
Ubiquitin-specific proteases in hepatitis: bridging molecular mechanisms and therapeutic potential
Goyal, K., Afzal, M., Bishoyi, A. K., Roopashree, R., Saini, S., Sharma, R. S. K., Pathak, P. K., Chauhan, A. S., Surendar, A., Imran, M., et al. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00434-y · Cited by 3
Shao, L., Zhang, B., Liu, J., Lyu, Z., Zhang, W., Yang, W., Fu, J., Wu, W., Zhong, X., Li, J., et al. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04361-5 · Cited by 3
Huang, X., Yu, R., Guo, M., Tan, X., Xia, Y., Zou, H., Liu, X., & Qin, C. (2025) · Nutrition Reviews · doi:10.1093/nutrit/nuaf145 · Cited by 3
Novel Therapies for Nonalcoholic Steatohepatitis (NASH) and Cardiovascular Risk Reduction
Biswas, T., Lehker, A., & Mukherjee, D. (2024) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/011871529x345190241113103911 · Cited by 3
Effects of stressogenic factors on the course of metabolic-associated fatty liver disease. Review
Kurinna, O. G. (2023) · Modern Gastroenterology · doi:10.30978/mg-2023-2-69 · Cited by 3
Абатуров, А. Е., & Нікуліна, А. О. (2025) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.21.3.2025.1545 · Cited by 3
Nonlinear association between TyG-BMI and MAFLD: A cross-sectional study
Wang, Q., Su, Y., Niu, J., Wang, Y., Liu, L., & Hao, Y. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331140 · Cited by 3
Ekra, J. E., Palit, P. K., Chowdhury, M. M. H., Sourna, I. J., Islam, S., Arefin, F., Zaman, M. A., Datta, J., Rahman, N., Anjum, A., et al. (2025) · Egyptian Liver Journal · doi:10.1186/s43066-025-00457-5 · Cited by 3
Chen, Y., Wang, C., Du, X., Sun, X., Song, W., & Lu, C. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1541421 · Cited by 3
Bao, S., Li, F., Duan, L., & Jiang, X. (2025) · International Journal of Endocrinology · doi:10.1155/ije/5528193 · Cited by 3
Risk of CKD in biopsy-proven metabolic dysfunction-associated steatotic liver disease
Ebrahimi, F., Eichhorn, C., Simon, T. G., Sun, J., Bergman, D., Marxer, C. A., Alkhatib, H., Bozorg, S. R., Hagström, H., Carrero, J. J., et al. (2026) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfag147 · Cited by 2
Recent advances in anterior pituitary hormones and metabolic-associated fatty liver disease
Liu, C., Long, Y., Liu, J., & Song, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1600559 · Cited by 2
Chen, S. J., Xu, D., Hu, D. K., Hu, P. J., & Huang, T. (2025) · JMIR Medical Informatics · doi:10.2196/75747 · Cited by 2
Qu, X., Jin, S., Shi, Y., Zhang, W., Cong, D., & Liu, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-31652-4 · Cited by 2
Diabetes Treatment and Prevention Using Herbal Medicine
Yusuf, B. O., Abdulsalam, R. A., & Sabiu, S. (2023) · Reference series in phytochemistry · doi:10.1007/978-3-031-21973-3_43-1 · Cited by 2
Mitrea, A., Vladu, I. M., Rosu, M. M., Clenciu, D., Moța, E., & Moța, M. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002510 · Cited by 2
Yaşar, A. B., & Ayhan, Z. Y. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04622-z · Cited by 2
He, M., Liu, Y., Gao, T., Gu, J., Zhou, X., Sun, Z., & Qiu, S. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261457476 · Cited by 2
Ling-Huan, B., He, L., Liu, X., Wu, J., Yang, Y., Yang, Y.-H., Deng, F.-Y., & Lei, S. (2025) · Annales d Endocrinologie · doi:10.1016/j.ando.2025.102454 · Cited by 2
Metadata
- Authors
- Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T.
- Affiliations
- The University of Tokyo (JP)
- National Institute of Biomedical Innovation, Health and Nutrition (JP)
- Toranomon Hospital (JP)
- Corresponding author
- Kubota, Naoto
- Kadowaki, Takashi
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-04-16
- Volume
- 22
- Issue
- 8
- Pages
- 4156
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8072900
- OpenAlex
- W3155254720
- Cited by
- 448
- References
- 195
- Citations by year
- 2026: 72 · 2025: 129 · 2024: 125 · 2023: 80 · 2022: 37 · 2021: 5
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (19K17977)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- non-alcoholic fatty liver disease, insulin resistance, hepatic insulin resistance, hepatic steatosis, liver fibrosis, de novo lipogenesis, gut microbiota, metabolic syndrome, obesity, type 2 diabetes, endoplasmic reticulum stress, liver inflammation, hepatocarcinogenesis
- MeSH terms
- Animals, Humans, Insulin, Signal Transduction, Metabolic Syndrome, Lipogenesis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.